hair loss semaglutide vs tirzepatide vs. for weight loss—what's the difference? 🤔Both have become GLP-1 receptor agonists (semaglutide, tirzepatide)

Despite accounting for 12.6% of global GLP-1 clinical trial activity in 2025, placing it third globally behind the US and China, prescribing rates for obesity indications remain comparatively low

Anton Bilchik, a renowned oncologist and expert in colorectal cancer, provides valuable insight into this complex issue

Heres what you should look out for

The clinical data in this regard is still very limited and needs expanding through randomized, placebo-controlled studies to draw final conclusions on whether polyphenols may be a class of clinically effective nutraceuticals in patients with CFS

References Talathi A, Talathi P

Monitoring: Key Health Markers to Track Regular monitoring ensures the stack is working as intended and catches potential issues before they become problems